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HerpesvirusHerpes simplex virus type 1 (HSV-1) UL37 is a 1123 amino acid tegument protein that self-associates and
binds to the tegument protein UL36 (VP1/2). Studies were undertaken to identify regions of UL37 involved in
these protein–protein interactions. Coimmunoprecipitation assays showed that residues within the carboxy-
terminal half of UL37, amino acids 568–1123, are important for interaction with UL36. Coimmunoprecipita-
tion assays also revealed that amino acids 1–300 and 568–1123 of UL37 are capable of self-association. UL37
appears to self-associate only under conditions when UL36 is not present or is present in low amounts,
suggesting UL36 and UL37 may compete for binding. Transfection–infection experiments were performed to
identify domains of UL37 that complement the UL37 deletion virus, KΔUL37. The carboxy-terminal region of
UL37 (residues 568–1123) partially rescues the KΔUL37 infection. These results suggest the C-terminus of
UL37 may contribute to its essential functional role within the virus-infected cell.l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Herpesvirus virions are composedof threemorphologically distinct
structures: the capsid, the tegument and the envelope (reviewed by
Roizman et al., 2007). The 150 kbp linear DNA genome is enclosed
within the icosahedral capsid. The virion is bounded by a host-derived
lipid envelope that contains approximately 12 virus-encoded glyco-
proteins (reviewed by Roizman et al., 2007). The proteinaceous region
between the capsid and envelope is termed the tegument. Approxi-
mately 25 virus-encoded proteins, as well as trace amounts of host
proteins, make up the tegument region (reviewed by Kelly et al., 2009;
Mettenleiter et al., 2009).
During herpesvirus replication, the viral genome is packaged into
assembled capsids within the nucleus of the infected cell. The capsid
acquires an envelope by budding into the inner nuclear membrane and
enters the perinuclear space. The capsid loses its primary envelope as it
subsequently fuses with the outer nuclear membrane and the capsid is
released into the cytoplasm(reviewedbyMettenleiter et al., 2009). It has
also been reported that capsids may escape the nucleus by exiting
through damaged nuclear pores (Leuzinger et al., 2005; Wild et al.,
2005). Detectable quantities of HSV-1 tegument proteins UL36 (VP1/2)
andUL37 (Bucks et al., 2007), as well as vhs (Read and Patterson, 2007),have been reported on capsids isolated from thenucleus.However, other
groups failed to detect HSV-1 UL36 and UL37 associatedwith detergent-
treated capsids isolated fromthenucleus of infected cells (Newcomband
Brown, 2010; Radtke et al., 2010; Trus et al., 2007;Wolfstein et al., 2006).
Other tegument proteins including HSV-1 VP16, HSV-1 VP22 and HSV
andpseudorabies virus (PRV)US3proteinshavebeen shown toassociate
with capsids within the perinuclear space (Granzow et al., 2004;
Naldinho-Souto et al., 2006; Padula et al., 2009; Reynolds et al., 2002),
suggesting the earliest events in tegumentation occur within these sites.
After exiting the nucleus the cytoplasmic capsids travel through the
secretory pathway. It has been suggested that some tegument proteins,
suchasHSV-1UL16, interactwith thecapsid as it travels in thecytoplasm
on its journey toward the trans-Golgi network (TGN) (Meckes andWills,
2007). The capsid obtains a lipid envelope by budding into vesicles
derived from the TGN. Many, if not all, tegument proteins are associated
with TGN-derived vesicles through membrane binding domains or
through interactions with membrane bound glycoproteins and/or
membrane bound tegument proteins. The TGN-membrane-associated
tegument proteins and glycoproteins are incorporated into the virion
during ﬁnal envelopment (Mettenleiter et al., 2009).
The morphogenesis and structure of the tegument appear to be
complex, with many details only recently being uncovered. With the
exception of the innermost layers, the tegument region is described as
asymmetrical in nature (Grunewald et al., 2003; Zhou et al., 1999).
Recent evidence suggests the tegument region may not be a static
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process after release of the virion from the infected cell (Newcomband
Brown, 2009). The maturation of the virion results in changes in
tegument structure including loss of protein symmetry surrounding
the capsid and increased resistance to detergent extraction (Newcomb
and Brown, 2009). There is also evidence that structural changes in the
tegument occur upon binding of the virion to the host cellular receptor
heparan (Meckes and Wills, 2008). Virion binding to the heparan
receptor causes the disassociation of at least one tegument protein,
UL16, from the capsid (Meckes and Wills, 2008).
A myriad of protein–protein interactions among tegument proteins
has been described, and these interactions likely play important roles in
facilitating the incorporation of tegument proteins into the assembling
virion. Two proteins of interest in this study are tegument proteins
encoded by the UL36 and UL37 genes. UL36, also known as VP1/2, binds
UL37 (Klupp et al., 2002). UL36 is the largest known herpesvirus-
encoded protein and theHSV-1-encodedUL36protein is approximately
270 kDa (Heine et al., 1974; Honess and Roizman, 1973; Spear and
Roizman, 1972). HSV-1 UL36 interacts with capsid proteins VP5 and
UL25 (Coller et al., 2007; McNabb and Courtney, 1992; Pasdeloup et al.,
2009), and is bound tightly to the capsid (Gibson and Roizman, 1972;
Spear and Roizman, 1972). UL36, and its homologues in all herpesvirus
subfamilies, functions as a deubiquitinating enzyme (Kattenhorn et al.,
2005; Schlieker et al., 2005). The conserved UL36 tegument protein is
important for productive infection, playing roles at early times, as well
as late times during infection. During translocation of incoming capsids
to the nucleus, UL36 associated with the incoming HSV-1 capsid is
cleaved, resulting in changes to the capsid that allow theviral genome to
be released into the nucleus (Jovasevic et al., 2008). Studies of HSV-1
and PRV UL36 deletion viruses indicate that in the absence of UL36,
DNA-ﬁlled capsids accumulate in the cytoplasm, are not associatedwith
appreciable amounts of tegument and do not undergo secondary
envelopment (Desai, 2000; Fuchs et al., 2004; Luxton et al., 2006;
Roberts et al., 2009). Furthermore, Luxton et al. (2006) reported that a
PRV UL36 deletion virus showed reduced microtubule-based transport
of capsids in the cytoplasm.
UL37 encodes a conserved 120 kDa phosphorylated tegument
protein (Albright and Jenkins, 1993; McLauchlan et al., 1994; Schmitz
et al., 1995; Shelton et al., 1990). UL37 is distributed throughout the
cell and contains a nuclear export signal (McLauchlan et al., 1994;
McLauchlan, 1997; Schmitz et al., 1995;Watanabe et al., 2000). HSV-1
UL37 functions to activate NF-κB signaling by binding TRAF6 (Liu
et al., 2008). The amount of HSV-1 UL37 packaged into the virion is
tightly controlled, as increasing expression of the protein does not
increase the abundance of UL37 in virions (McLauchlan, 1997).
During virus assembly UL37may have a function in the cytoplasm as
well as the nucleus. In cells infected with a mutant virus containing a
deletion of HSV-1 UL37, KΔUL37, DNA-ﬁlled capsids accumulate in the
nucleus (Desai et al., 2001); however, in cells infected with another
HSV-1 UL37 deletion virus, ΔUL37[86–1035], an accumulation of nu-
clear capsids was not observed (Leege et al., 2009). Roberts and
colleagues constructed a third HSV-1 UL37 deletion virus, FRΔUL37.
Infection with FRΔUL37 did not result in an accumulation of capsids in
the nucleus but yielded an accumulation of large aggregates of cyto-
plasmic capsids, similar to capsid aggregates also observed in KΔUL37-
infected cells (Desai et al., 2001; Roberts et al., 2009). None of the HSV-1
UL37 deletion viruses yield productive infections (Desai et al., 2001;
Leege et al., 2009; Roberts et al., 2009). PRV UL37 deletion viruses
produced titers approximately 100- to 1000-fold lower than wild type
and showedno accumulation of capsidswithin the nucleus (Klupp et al.,
2001; Luxton et al., 2006). Secondary envelopment is inhibited inHSV-1
and PRV UL37 deletion viruses, resulting in an accumulation of capsids
in the cytoplasm (Desai et al., 2001; Klupp et al., 2001; Leege et al., 2009;
Luxton et al., 2006; Roberts et al., 2009).
Coimmunoprecipitation and yeast two-hybrid interaction studies
have revealed that HSV-1 UL37 may interact with several other viralproteins. In a yeast two-hybrid analysis, HSV-1 UL37 interacts with
the capsid proteins VP26 and VP19c (Lee et al., 2008). UL37 also
participates in interactions with other tegument proteins, including
UL46 and UL36 (Fossum et al., 2009; Klupp et al., 2002; Lee et al.,
2008; Uetz et al., 2006; Vittone et al., 2005). Furthermore, HSV-1 UL37
interacts with itself, as indicated by yeast two-hybrid analysis and
coimmunoprecipitation studies (Lee et al., 2008; Vittone et al., 2005).
Based on its tight associationwith the capsid, it has been suggested
that UL36 may be one of the ﬁrst tegument proteins to associate with
the capsid, and may act as a foundation to bind other tegument
proteins to the capsid (Mettenleiter et al., 2009). Studies revealing the
association of HSV-1 UL36 and UL37 with capsids isolated from the
nuclear fraction also support this hypothesis (Bucks et al., 2007). The
interaction of UL36 with the capsid may aid or enhance the incor-
poration of UL36 binding partners, such as UL37 or VP16 (Ko et al.,
2010; Lee et al., 2008; Mettenleiter et al., 2009; Vittone et al., 2005).
UL36 and UL37 physically interact, but the functional importance of
the interaction is perhaps only beginning to be understood (Klupp
et al., 2002). Desai et al. (2008) reported that the localization of HSV-1
UL37 in the Golgi complex is dependent on UL36. Furthermore, based
upon the work of Roberts et al. (2009), HSV-1 UL36 and UL37 appear
to rely on one another for incorporation into L particles. Interestingly,
the incorporation of UL37 and UL36 into L particles may be dependent
on VP16, as L particles produced from a PRV VP16 deletion mutant,
PRV-ΔUL48, do not contain these proteins (Fuchs et al., 2002). Con-
sistent with this ﬁnding, HSV-1 UL36 has been reported to interact
with VP16 in yeast two-hybrid and pulldown assays (Ko et al., 2010;
Lee et al., 2008; Vittone et al., 2005).
Vittone et al. (2005) have determined that the region containing
amino acids 512–767 of HSV-1 UL36 is necessary for binding UL37.
Mijatov et al. (2007) extended these studies to identify residues F593
and E596 of HSV-1 UL36 as essential for the interaction. Furthermore,
Fuchs and colleagues have reported that deletion of the UL37 binding
domain of UL36 does not abolish PRV replication, suggesting that the
essential function(s) of UL36 is not dependent on binding UL37 (Fuchs
et al., 2004). The region of UL37 that participates in its interaction
with UL36, as well as the region(s) of UL37 that participates in self-
association, have not been identiﬁed and are the focus of our report.
These studies are important for several reasons. First, the interaction of
UL36 and UL37 is conserved among the alpha-, beta-, and gamma-
herpesviruses (Bechtel and Shenk, 2002; Klupp et al., 2002; Lee et al.,
2008; Rozen et al., 2008; Uetz et al., 2006; Vittone et al., 2005).
Furthermore, UL36 plays an essential role in the assembly of HSV-1
and PRV (Desai, 2000; Fuchs et al., 2004; Luxton et al., 2006; Roberts
et al., 2009). In addition, UL37 plays an essential role for assembly of
HSV-1 and varicella zoster virus (VZV) and a critical role in the as-
sembly of PRV (Desai et al., 2001; Klupp et al., 2001; Luxton et al., 2006;
Pasdeloup et al., 2010; Roberts et al., 2009; Xia et al., 2003). A greater
understanding of the interaction between UL36 and UL37 will help
elucidate the role(s) that the UL36-UL37 interaction plays during
assembly of herpesvirus virions. We have identiﬁed a region within
the carboxy-terminal half of HSV-1 UL37 to be necessary for binding to
UL36. Furthermore, we have determined that both carboxy- and
amino-terminal regions of UL37 are capable of self-association, and
can interact with one another. In a trans-complementation assay,
when plasmids encoding UL37 truncation mutants were transfected
into cells followed by infection with a UL37 deletion virus, a mutant
protein encompassing the carboxy-terminal half of UL37 was found to
complement the infection with the UL37 deletion virus.
Results
Identiﬁcation of the region of UL37 involved in binding UL36
A series of hemagglutinin (HA) tagged UL37 truncation mutants
was constructed and used in coimmunoprecipitation assays to identify
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mutants were designed to avoid major disruptions in secondary
structure that may result from protein truncations in the middle of
hydrophobic regions. A GFP-expressing plasmid encoding the region
of UL36 necessary for binding UL37, amino acids 512–767, was
generated (UL36.512-767GFP). N-terminal and C-terminal truncation
mutants of UL37, containing a hemagglutinin (HA) tag at the carboxy-
terminus, were cotransfected into Vero cells with UL36.512-767GFP.
Cells were lysed in NP40 lysis buffer and the nuclear fraction was
discarded. The detergent lysis buffer presumably solubilizes cytoplas-
mic membranes, resulting in the disruption of cytoplasmic compart-
ments and release of all cytoplasmic proteins to potentially interact inFig. 1. Coimmunoprecipitation of UL36.512-767GFP with N-Terminal and C-Terminal
UL37HA Truncation Mutants. (A) A schematic representation of HA tagged full-length,
N-terminal and C-terminal UL37 truncation mutants. Additionally, a tabular summary
of results indicate the UL37HA truncation mutants that bind (+) or do not bind (−)
UL36.512-767GFP (UL36GFP) in coimmunoprecipitation assays. Molecular weight
values were predicted by Statistical Analysis of Protein Sequence accessed through
SDSC BiologyWorkbench. (B) Expression of UL37HA truncationmutants and UL36.512-
767GFP. Vero cells were cotransfected with UL36.512-767GFP and the indicated
UL37HA constructs, harvested at 24 h post-transfection and lysed in NP40 lysis buffer.
Each cytoplasmic lysate was analyzed by Western blotting using rabbit HA antibody
(αHA, top panel) or goat GFP antibody (αGFP, bottom panel). (C) Coimmunoprecipita-
tion of UL36.512-767GFP with UL37 HA constructs. Cotransfected cytoplasmic lysates
were incubated with an anti-HA rabbit antibody and then bound to protein G-agarose
beads. Immunoprecipitatedmaterial was separated on an SDS-PAGE gel and transferred
to nitrocellulose. Proteins were detected by Western blotting using a goat anti-HA
antibody (αHA, top panel) or goat anti-GFP antibody (αGFP, bottom panel).
Fig. 2. Analysis of the ability of UL36.512-767GFP to interact with a UL37HA mutant
lacking residues 568–809. (A) A schematic representation of the UL37HA mutants.
UL37HA mutants were cotransfected into Vero cells with UL36.512-767GFP. A tabular
summary of results indicate the UL37HA truncation mutants that bind (+) or do not
bind (−) UL36.512-767GFP (UL36GFP) in coimmunoprecipitation assays. Molecular
weight values were predicted by Statistical Analysis of Protein Sequence accessed
through SDSC BiologyWorkbench. Immunoprecipitation andWestern blot analysis was
performed as described in the legend to Fig. 1. (B) Expression of the GFP and HA fusion
proteins in whole cell lysates was analyzed by Western blotting with rabbit anti-HA
(αHA, top panel) and rabbit anti-GFP (αGFP, bottom panel) antibodies. (C) The ability
of the UL37HA mutants to bind UL36.512-767GFP was analyzed by Western blotting
membranes of the coimmunoprecipitated material with goat anti-GFP antibody (αGFP,
bottom panel). Rabbit anti-HA antibody and rabbit TrueBlot HRP-conjugated anti-
rabbit secondary antibody was used to verify immunoprecipitated UL37HA constructs
(αHA, top panel).coimmunoprecipitation experiments. Anti-HA antiserum was used to
immunoprecipitate the UL37HA mutant proteins. Immune complexes
were captured by incubating the lysateswith protein G-agarose beads.
SDS-PAGE and Western blotting were performed to verify expression
of the cotransfected plasmids (Fig. 1B) and identify the UL37HA mu-
tants capable of coimmunoprecipitating UL36.512-767GFP (Fig. 1C).
As expected, full-length UL37HA coimmunoprecipitated UL36.512-
767GFP. UL37 mutants encoding amino acids 1–300 or 1–567 of UL37
did not coimmunoprecipitate UL36. Extension of the amino-terminal
mutants to include residues 1–809 restored binding to UL36. Fur-
thermore, mutants UL37.568-1123HA and UL37.301-1123HA were
also capable of binding UL36.512-767.GFP. These results suggest that
residues 568–809 of UL37 are important for interaction with UL36.
To further address the role that amino acids 568–809 of UL37 play
in the interaction with UL36, a UL37 mutant containing an internal
deletion of these amino acids, UL37.Δ568-809HA, was constructed
(Fig. 2A). Vero cells were cotransfected with UL37HA constructs and
UL36.512-767GFP, subsequently lysed for coimmunoprecipitation
with anti-HA antiserum, and protein interactions visualized by SDS-
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cell lysates is shown in Fig. 2B. Immunoprecipitated material is
presented in Fig. 2C. As also seen in Fig. 1, truncation mutants UL37.1-
809HA, UL37.568-1123HA and UL37.301-1123HA coimmunoprecipi-
tated UL36.512-767GFP. When analyzed in coimmunoprecipitation
assays, deletion of amino acids 568–809 within full-length UL37 de-
creased binding to UL36 to nearly background levels (Fig. 2C). This
result suggests that amino acids 568–809 of UL37 are functionally
important for the interaction of UL36 and UL37, or alternatively this
region plays an integral role in the structure of UL37 that is necessary
for its interaction with UL36.
Results shown in Figs. 1 and 2 suggest that amino acids 568–809 of
UL37 are necessary for the interaction with UL36. Experiments were
performed to determine if these amino acids are sufﬁcient to enableFig. 3. Coimmunoprecipitation of UL36.512-767GFP with Internal UL37HAMutants. (A)
A schematic representation of the internal UL37HA truncation mutants. Plasmids
encoding internal domains of UL37HA were cotransfected into Vero cells with
UL36.512-767GFP. Immunoprecipitation and Western blot analysis was performed as
described in the legend to Fig. 1. A tabular summary of results indicate the UL37HA
truncation mutants that bind (+) or do not bind (−) UL36.512-767GFP (UL36GFP) in
coimmunoprecipitation assays. Molecular weight values were predicted by Statistical
Analysis of Protein Sequence accessed through SDSC Biology Workbench. (B)
Expression of the GFP and HA fusion proteins in whole cell lysates was analyzed by
Western blotting with rabbit anti-HA (αHA, top panel) and rabbit anti-GFP (αGFP,
bottom panel) antibodies. (C) The ability of the internal UL37HA mutants to bind
UL36.512-767GFP was analyzed by Western blotting membranes of the coimmuno-
precipitated material with goat anti-GFP antibody (αGFP, bottom panel). Rabbit anti-
HA antibody and rabbit TrueBlot HRP-conjugated anti-rabbit secondary antibody was
used to verify immunoprecipitated UL37HA constructs (αHA, top panel).UL36 binding. HA tagged UL37 truncation mutants containing amino
acids 568–809, or aminoacids extendingoutward from that regionwere
generated (Fig. 3A). Plasmids encoding the UL37HA truncationmutants
and UL36.512-767GFP were cotransfected into cells and analyzed by
coimmunoprecipitation and Western blotting. Several of the internal
UL37 mutants reproducibly exhibited relatively low protein expression
as compared to the full-length protein (Fig. 3B).When the internal UL37
mutants were immunoprecipitated with anti-HA antisera, Western
blottingwith anti-GFP antisera revealed that UL36.512-767GFP failed to
coimmunoprecipitate with any of the internal UL37HAmutant proteins
(Fig. 3C). These results suggest that although amino acids 568–809 of
UL37 are necessary for interaction with UL36, they are not sufﬁcient for
this interaction. The failure of the UL37HA truncation mutants to bind
UL36 may suggest that amino acids outside the region of 568–809 areFig. 4. Coimmunoprecipitation of UL36.512-767GFP with Additional Internal UL37HA
Mutants. (A) A schematic representation of the internal UL37 truncation mutants.
Plasmids encoding internal domains of UL37HA were cotransfected into Vero cells with
UL36.512-767GFP. Immunoprecipitation and Western blot analysis was performed as
described in the legend to Fig. 1. A tabular summary of results indicate the UL37HA
truncation mutants that bind (+), do not bind (−) or reproducibly bind UL36.512-
767GFP (UL36GFP) weakly (wk) in coimmunoprecipitation assays. Molecular weight
values were predicted by Statistical Analysis of Protein Sequence accessed through
SDSC Biology Workbench. (B) Expression of the GFP and HA fusion proteins in whole
cell lysates was analyzed by Western blotting using rabbit anti-HA (αHA, top panel)
and rabbit anti-GFP (αGFP, bottom panel) antibodies. (C) The ability of the internal
UL37HA mutants to bind UL36.512-767GFP was analyzed by Western blotting the
immunoprecipitated material with goat anti-GFP antibody. Rabbit anti-HA antibody
and rabbit TrueBlot HRP-conjugated anti-rabbit secondary antibody was used to verify
immunoprecipitated UL37HA constructs.
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tion of UL37 necessary for its interaction with UL36.
As shown in Figs. 1 and 2, the C-terminal half of UL37, containing
residues 568–1123, is sufﬁcient for binding UL36.512-767GFP. In an
effort to deﬁne a smaller region of UL37 that is sufﬁcient for UL36
binding, additional HA tagged plasmids encoding internal regions of
UL37 were constructed (Fig. 4A). UL37HA truncation mutants and
UL36.512-767GFP were cotransfected into cells to be used in coimmu-
noprecipitation assays. Protein expression (Fig. 4B) and protein inter-
actions (Fig. 4C)were visualized by SDS-PAGE andWestern blotting. The
internal UL37HA truncation mutants reproducibly displayed multiple
protein bands, suggestive of protein degradation. The GFP Western blot
of cell lysates (Fig. 4B, bottom panel) depicts multiple protein bands inFig. 5. Coimmunoprecipitation of UL37HA with GFP-tagged N-terminal and C-terminal
UL37 truncation mutants. (A) A schematic representation of full-length, N-terminal and
C-terminal UL37 truncationmutants fused to GFP. A tabular summary of results indicate
the UL37GFP truncation mutants that bind (+) or do not bind (−) UL37HA in
coimmunoprecipitation assays. Molecular weight values were predicted by Statistical
Analysis of Protein Sequence accessed through SDSC Biology Workbench. (B)
Expression of the UL37 constructs. Vero cells cotransfected with the indicated
constructs were harvested approximately 24 h post-transfection and lysed in NP40
lysis buffer. A fraction of the cytoplasmic lysates was analyzed using rabbit antibodies to
GFP (αGFP, top panel) and HA (αHA, bottom panel). (C) Coimmunoprecipitation of
UL37GFP constructs with UL37HA. Transfected cell lysates were incubated with goat
anti-GFP antibody and then bound to protein G-agarose beads. Immunoprecipitated
material was analyzed on a SDS-PAGE gel and transferred to nitrocellulose. Proteins
were detected by Western blotting using rabbit antibodies to GFP (αGFP, top panel)
and HA (αHA, bottom panel).the UL37.489-1021 sample due to incomplete stripping of anti-HA
antibody from the membrane before the GFP Western blot was
performed. Coimmunoprecipitation with anti-HA antibody showed
that UL37 truncation mutants encoding amino acids 391–1021 or 743–
1123 do not reproducibly bind UL36.512-767GFP above background
levels. However, UL37 truncation mutants containing amino acids 489–
1021, 568–1021, or 624–1123 coimmunoprecipitated UL36.512-
767GFP, although binding is markedly lower than binding with full-
length UL37. The smallest truncation mutant of UL37 that facilitates an
interaction with UL36 is UL37.568-1021HA. Together, these results
suggest that amino acids 624–1021 would also be sufﬁcient for inter-
action with UL36. To address this issue a UL37 truncation mutant
expressing amino acids 624–1021 was constructed and analyzed in
coimmunoprecipitation assays as described above. Surprisingly,
UL37.624-1021HAwas not able to interact with UL36, although protein
expression was considerably less than full-length UL37 (data not
shown). Collectively, these coimmunoprecipitation studies indicate
that residues 568–809 of UL37 are necessary for interaction with UL36.
Amino acids 568–809 may directly interact with UL36 or, alternatively,
deletion of this region may cause major disruptions in the protein
structure, thus inhibiting the interaction with UL36. The carboxy-
terminal half of UL37 is sufﬁcient for interaction with UL36, but further
truncation of this region results in little, if any, binding to UL36. These
results suggest that UL37 may be conformationally sensitive to
truncations within the carboxy-terminus.
Identiﬁcation of domains involved in self-association of UL37
UL37 has been shown by yeast two-hybrid and coimmunoprecipita-
tion assays to self-associate (Lee et al., 2008; Vittone et al., 2005). To
ascertain the region(s) of UL37 involved in self-association of the
protein, GFP-tagged UL37 truncationmutantswere generated (Fig. 5A).
A plasmid encoding full-length UL37HA was cotransfected into cells
with plasmids encoding UL37GFP truncation mutants. Protein inter-
actionswere assayed by coimmunoprecipitationwith anti-GFP antisera.
Western blotting with rabbit antibodies to GFP and HA were used to
verify protein expression (Fig. 5B). Anti-HA immunoblots show that
truncationmutants encoding either N-terminal or C-terminal regions of
UL37 were capable of interacting with full-length UL37HA (Fig. 5C).
UL37 truncation mutants containing amino acids 1–809, 1–300, 301–
1123 or 589–1123 were able to coimmunoprecipitate full-length
UL37HA (Fig. 5C). A construct encoding amino acids 1–567 repeatedly
did not interact with UL37HA in binding assays; this is an intriguing
observation because a smaller truncation mutant encoding amino acids
1–300 does bind full-lengthUL37HA. This ﬁnding suggests that removal
of the C-terminal half of UL37GFPmay cause the protein tomisfold, thus
blocking its ability to bind UL37HA. However, further truncation of the
UL37GFP mutant from the C-terminus, resulting in UL37.1-300GFP,
restores binding to UL37HA, possibly by exposing an amino-terminal
UL37 self-association domain that was presumably masked or mis-
folded in UL37.1-567GFP.
UL37 appears to contain two domains involved in interaction with
full-length UL37, residues 1–300 and 568–1123. Cells were cotrans-
fected with HA- and GFP-tagged UL37 constructs and coimmunopre-
cipitation assays were used to determine if the amino and carboxy-
terminal interaction domains bind to one another and if the mutant
UL37 domains self-interact (Fig. 6A). In UL37 binding assays, UL37.1-
567GFP, which does not bind full-length UL37, was used as a negative
control. Protein expression was assayed by Western blotting cyto-
plasmic lysateswith anti-HA (top panels) and anti-GFP (bottompanels)
antibodies (Fig. 6B, D and F). Immunoprecipitation with anti-GFP
antisera and Western blotting with anti-HA antibody revealed that
UL37.1-300HA and UL37.568-1123GFP interact in cotransfected cells
(Fig. 6C). Binding assays also showed that UL37.1-300GFP is capable of
binding UL37.1-300HA and that UL37.568-1123GFP is capable of inter-
acting with UL37.568-1123HA (Fig. 6C and E, respectively). Fig. 6G
Fig. 6. Interactions of amino- and carboxy-terminal UL37 self-association domains
analyzed by coimmunoprecipitation–Western blot analysis. (A) A schematic representa-
tion of the UL37 N-terminal and C-terminal HA and GFP fusion constructs used in the
coimmunoprecipitation assays. A tabular summary of results indicate the UL37GFP
truncation mutants that bind (+) or do not bind (−) UL37HA truncation mutants in
coimmunoprecipitation assays. Possible combinations of coimmunoprecipitations that
werenot tested are indicatedby “nt.” (B, D, and F)Expressionof cotransfectedUL37HAand
UL37GFPmutants. Vero cellswere cotransfectedwith the indicated plasmids, harvested at
approximately 24 h post-transfection and lysed in NP40 lysis buffer. A portion of each
cytoplasmic lysate was analyzed for protein expression using rabbit antibodies to HA
(αHA, top panels) andGFP (αGFP, bottompanels). (C, E, andG)Coimmunoprecipitationof
UL37 HA-tagged and UL37 GFP-tagged mutant proteins. Coimmunoprecipitations were
performed and analyzed as described in the legend to Fig. 5. Western blotting with rabbit
anti-HA (αHA, top panels) and anti-GFP (αGFP, bottom panels) antibodies was used to
determine if the UL37HA mutants coimmunoprecipitated with the GFP fusion constructs.
Fig. 7. Coimmunoprecipitation of UL37HA and UL37.Δ568-809GFP. (A) A schematic
representation of the UL37GFP constructs cotransfected with full-length UL37HA
construct. A tabular summary of results indicate the UL37GFP truncation mutants that
bind (+) or do not bind (−) UL37HA in coimmunoprecipitation assays. Molecular
weight values were predicted by Statistical Analysis of Protein Sequence accessed
through SDSC Biology Workbench. (B) Expression of UL37HA. Vero cells cotransfected
with the indicated constructs were harvested at approximately 24 h post-transfection
and lysed in NP40 lysis buffer. A portion of the cytoplasmic lysates was analyzed for
protein expression using a rabbit anti-HA antibody. (C) Coimmunoprecipitation of
UL37.Δ568-809GFP with UL37HA. Coimmunoprecipitations were performed and
analyzed as described in the legend to Fig. 5. Coimmunoprecipitated proteins were
detected by Western blotting with rabbit anti-GFP (αGFP, bottom panel) and rabbit
anti-HA (αHA, top panel) antibodies.
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acids 1–567 are not capable of self-association, further suggesting that
this mutant protein may lack proper structure that enables self-
interaction. These results suggest that UL37 contains two domains in-
volved in self-association of the protein. Mutants encoding either of the
interaction domains are capable of self-association with full-length
UL37 and the two interaction domains can be coimmunoprecipitated in
a complex. Furthermore, HA-tagged mutants encoding residues 1–300
or 568–1123 can self-interact with GFP-tagged mutants encoding
residues 1–300 or 568–1123, respectively.
Results from UL36-UL37 binding assays indicated that amino acids
568–809 of UL37 are necessary for the interaction with UL36 (Figs. 1
and 2). It is possible that deletion of amino acids 568–809 of UL37
causes the protein to misfold, thus inhibiting protein–protein in-
teractions. To determine if an internal deletion of this region of UL37negatively affects self-association of UL37,we generated a UL37.Δ568-
809GFPmutant to be used in coimmunoprecipitation studies. Plasmids
encoding UL37.Δ568-809GFP and UL37HA were cotransfected into
cells, lysed and analyzed by coimmunoprecipitation with anti-GFP
antisera. Immunoblots with anti-HA antisera indicate that residues
568–809 of UL37 are not sufﬁcient for self-association of UL37. UL37.
Δ568-809GFP coimmunoprecipitated UL37HA, indicating that amino
acids 568–809 of UL37 are not necessary for the self-interaction
(Fig. 7C). These results suggest that this region, amino acids 568–809,
is integral for the interaction with UL36 but not for self-association of
UL37.
Do UL37 and UL36 compete for binding to UL37?
UL37 contains two self-association domains, amino acids 1–300 and
568–1123. The UL36 binding domain of UL37 overlaps the C-terminal
UL37 self-association domain. In the infected cell, UL37 and UL36 are
present in the cytoplasm and nucleus at approximately the same times.
These observations raise the questionwhether UL36 and UL37 compete
for binding to UL37. Coimmunoprecipitation studies were used to
determine if UL37 is capable of binding UL37 and UL36 simultaneously
or if one binding reaction inhibits the other. Cells were cotransfected
with UL37GFP, UL37HA and increasing amounts of UL36.512-767GFP
plasmids. Cells were lysed, proteins were coimmunoprecipitated with
Fig. 8. Coimmunoprecipitation Analysis of UL37HAwhen Coexpressedwith UL37GFP and UL36.512-767GFP. (A) Vero cells were cotransfected with the indicated amounts UL36.512-
767GFP, UL37HA and UL37GFP plasmids. At approximately 24 h post-transfection, cells were harvested, lysed in NP40 lysis buffer and a portion of the cytoplasmic lysate was
analyzed for protein expression byWestern blotting using goat anti-GFP antibodies. Arrows indicate the positions of UL37GFP and UL36.512-767GFP. (B) Coimmunoprecipitation of
UL37GFP and/or UL36.512-767GFP with UL37HA. Coimmunoprecipitation with anti-HA antisera was performed as described in the legend to Fig. 1. Immunoprecipitated material
was analyzed byWestern blot analysis using a goat anti-HA antibody (αHA, top panel) and goat anti-GFP antibody (αGFP, bottom panel). Arrows indicate the positions of UL37GFP
and UL36.512-767GFP in the bottom panel.
Fig. 9. Transfection–infection experiments to assess the ability of UL37HA mutants to
complement the KΔUL37 virus. Vero cells were transfected with the indicated UL37HA
constructs, and approximately 24 h later infected with KΔUL37 virus with an MOI of 1.
Approximately 48 h after infection, cells and media were harvested and lysed by three
cycles of freeze/thaw. Cellular debris was pelleted and the supernatant was titered on
UL37-expressing cells (BD45) to quantitate the amount of infectious virus released.
Titrations for each UL37 construct represent the average of a minimum of three
independent experiments; error bars represent the calculated standard error of
measurement (SEM). For each independent experiment, the titers were compared by
determining the percent of virus released as compared to UL37HA (%PFU/ml for the
UL37HA sample equals 100% for each experiment).
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andWestern blotting.Western blotting of cytoplasmic lysateswith anti-
GFP antibody veriﬁed protein expression of both GFP-expressing plas-
mids (Fig. 8A). Western blotting of the immunoprecipitated material
with anti-GFP antisera was used to determine if UL37GFP and/or
UL36.512-767GFP coimmunoprecipitatedwith UL37HA.When 0.5 μg of
plasmid encoding UL36.512-767GFP was cotransfected into cells with
plasmids encoding UL37HA and UL37GFP, anti-GFP Western blots
revealed that both UL37GFP and UL36.512-767GFP coimmunoprecipi-
tated with UL37HA (Fig. 8B). Thus, under relatively low levels of
expression of UL36.512-767GFP, UL37GFP bound UL37HA (Fig. 8B).
However, as the expression of UL36.512-767GFP protein increased, the
amount of UL37GFP that coimmunoprecipitated with UL37HA de-
creased. The self-interaction of UL37HA andUL37GFP appeared to occur
only when UL36.512-767GFP is not present in high quantities. Similar
results from seven independent experiments indicated that appreciable
expression of UL36.512-767GFP inhibits self-association of UL37HA and
UL37GFP in coimmunoprecipitation experiments. Furthermore, expres-
sion of UL37HA was increased by transfecting greater amounts of DNA,
but the increased expression of UL37HA failed to restore UL37GFP
interactionwith UL37HA in the presence of UL36.512-767GFP (data not
shown). Based on these results it appears that UL37GFP and UL36.512-
767GFP compete for binding to UL37HA. This suggests that UL37HA
does not bind UL37GFP and UL36.512-767GFP simultaneously.
Identiﬁcation of domains of UL37 that complement the UL37 deletion
virus, KΔUL37
UL37 is necessary for assembly of HSV-1 virions; in the absence of
UL37 proper tegumentation and secondary envelopment do not occur
(Desai et al., 2001; Roberts et al., 2009). A trans-complementation
assay was designed to determine the regions of UL37 that rescue the
replication deﬁcient KΔUL37 virus to result in the production of
infectious virions. Vero cells were transfected with the indicated
mutant UL37HA plasmids and 24 h later infected with KΔUL37.
UL46HA was transfected as a negative control. At 48 h after infection,cells and media were collected and subjected to three rounds of
freeze/thaw, cellular debris was pelleted and infectious virions were
quantiﬁed by plaque assay on BD45 cells (Vero cells that stably
express UL37). Western blotting of the transfected-infected cell
lysates was performed to verify expression of each of the transfected
plasmids. All plasmids used in this study contained the immediate
early CMV promoter and produced robust protein expression of all
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The amounts of infectious virions released from cells transfected with
UL37HAmutants were determined and are represented as the percent
of PFU/ml as compared to virions released from cells transfected with
full-length UL37HA (Fig. 9). Plaque assays revealed that a mutant
protein encoding the C-terminal half of UL37, residues 568–1123, was
capable of rescuing the KΔUL37 virus to approximately 12% of the
levels, or approximately one log less than the amount releasedwhen a
plasmid encoding full-length UL37HA is transfected (Fig. 9). The other
tested UL37HAmutants yielded viral titers comparable to the UL46HA
control sample. These results indicate that the carboxy-terminal half
of UL37 confers partial complementation to the replication defective
KΔUL37 virus. This result suggests that this region of UL37, which is
involved in binding UL36 and self-association, may play an essential
functional role during virus infection.
Does UL37.568-1123HA interact with UL36 in infected cells?
Results shown in Fig. 9 indicate that UL37.568-1123HA partially
rescues the KΔUL37 virus. UL37.568-1123HA interactswith UL36.512-
767GFP in cotransfected cells (Figs. 1 and 2). To determine if the ability
of UL37.568-1123HA to rescue the KΔUL37 virus was possibly due to
its ability to interact with UL36, it was necessary to demonstrate that
UL37.568-1123HA interacts with virus-expressed full-length UL36. A
coimmunoprecipitation assay from transfected-infected cells was
utilized to address this question. To minimize the risk of coimmuno-
precipitating UL37.568-1123HA and UL36 bound to a large capsidFig. 10. Coimmunoprecipitation of virus-expressed full-length UL36 with UL37.568-
1123HA. Vero cells were transfected with the indicated UL37HA plasmids and 24 h later
infected with K23Z HSV-1 at anMOI of 10. Approximately 24 h post-infection cells were
harvested and immunoprecipitation was performed as described in the legend to Fig. 1.
(A) Each cytoplasmic lysate was analyzed byWestern blotting using rabbit HA antibody
(αHA, top panel) or rabbit UL36 antibody (αUL36, bottom panel). (B) The ability of
K23Z-expressed full-length UL36 to bind UL37HA constructs was analyzed by Western
blotting the membranes of the coimmunoprecipitated material with rabbit anti-UL36
antibody (αUL36, bottom panel) and rabbit TrueBlot HRP-conjugated anti-rabbit
secondary antibody. Western blotting with rabbit anti-HA antibody and rabbit TrueBlot
HRP-conjugated anti-rabbit secondary antibody veriﬁed imunoprecipitated UL37HA
complexes.complex, transfected cells were infectedwith K23ZHSV-1 (Desai et al.,
1993), in which capsid formation is abrogated. Therefore, K23Z-
infected cells allowed the examination of the UL36 interaction with
UL37.568-1123HA in the absence of capsid formation. Cells were
transfected with the indicated UL37HA plasmids and 24 h later
infected with K23Z HSV-1. Approximately 24 h after infection, cells
were lysed, proteins were coimmunoprecipitated with anti-HA
antisera and immune complexes were visualized by SDS-PAGE and
Western blotting. Western blotting using anti-HA antiserum and anti-
UL36 antiserum veriﬁed expression of the transfected plasmids and
viral UL36, respectively (Fig. 10A). Immunoblots with anti-UL36
antiserum indicate that K23Z-expressed UL36 coimmunoprecipitated
with full-length UL37HA (Fig. 10B). As a negative control, cells were
transfected with UL37.1-567HA which does not interact with
UL36.512-767GFP. As expected, K23Z-expressed UL36 did not coim-
munoprecipitate with UL37.1-567HA. In contrast, K23Z-expressed
UL36 coimmunoprecipitated with UL37.568-1123HA. These results
indicate that UL37.568-1123HA interacts with full-length UL36 in
infected cells.
Discussion
The studies described within this report were designed to identify
domains of the UL37 tegument protein involved in its self-association,
as well as its interaction with UL36. To our knowledge, these are the
ﬁrst studies identifying domains of UL37 involved in these in-
teractions. These studies will help elucidate the role of the interaction
betweenUL36 and UL37 and the role that self-association of UL37 play
during viral assembly. A schematic summary of domains and epitopes
of UL37 identiﬁed by this report and others is presented in Fig. 11.
Several observations throughout these studies suggested that the
conformation of UL37 may be sensitive to mutations. First, UL37.1-
567HA was the only truncation mutant that did not interact with full-
length UL37. Although UL37.1-567HA contains the amino-terminal
self-association sequence (amino acids 1–300); UL37.1-567HA did not
interactwith either of the self-associationdomains (regions 1–300 and
568–1123). These results suggest that due to truncation, the structural
conformation of UL37.1-567HA may be altered in such a way that
inhibits the self-interaction of UL37. Results frommapping the domain
of UL37 involved inUL36 binding also suggest that the conformation of
UL37 is sensitive to truncations. The carboxy-terminal half of UL37,
encompassing amino acids 568–1123, is sufﬁcient for interaction with
UL36. However, deletion of 102 amino acids from the unconserved C-
terminus of UL37 yields a truncation mutant, UL37.568-1021HA, that
binds UL36 at low levels. Furthermore, UL37.624-1123HA showed low
levels of binding to UL36 (Fig. 4). Collectively, these results suggested
that a smaller construct encoding amino acids 624–1021 would also
bind UL36. However, when a plasmid encoding this region was con-
structed and analyzed in coimmunoprecipitation assays, UL37.624-
1021HA failed to bind UL36 (data not shown), suggesting that amino
acids surrounding this region within the carboxy-terminus are
important in maintaining the conformation of UL37 needed to bind
UL36. Interestingly, Luxton and colleagues reported that a GFP tag on
the amino-terminus of PRV UL37 was deleterious for viral growth,
perhaps suggesting that GFP at this position disrupts the conformation
of UL37 (Luxton et al., 2005). Furthermore, Antinone and Smith (2010)
also reported that a GFP tag on the amino-terminus of HSV-1 UL37
decreased viral titers by nearly one order of magnitude.
The studies presented in this manuscript do not investigate the
possibility that cellular and/or viral proteins may bridge the inter-
action of UL36 and UL37. Previous studies have reported the HSV-1
UL36 and UL37 interaction, as well as HSV-1 UL37 self-association, in
yeast two-hybrid and coimmunoprecipitation studies in the absence
of other viral proteins (Lee et al., 2008; Vittone et al., 2005). Fur-
thermore, coimmunoprecipitation results presented in this manu-
script demonstrate that additional viral proteins are not necessary to
Fig. 11. Schematic representation of identiﬁed domains and epitopes of UL37. Amino acids 1–300 function as a UL37 multimerization domain (N UL37-UL37 dom), an alanine-rich
region encompasses residues 44–80 (ARR), a leucine zipper motif spans residues 203–224 (L Zip) and a leucine-rich region at amino acids 263–272 functions as a nuclear export
signal (LRR/NES) (Watanabe et al., 2000). The C-terminal half of UL37, amino acids 568–1123, functions as a UL37 self-association domain (C UL37-UL37 dom), is involved in binding
UL36 (UL36-UL37 dom) and this region partially complements the KΔUL37 virus in transfected cells (Resc. KΔUL37). UL37 activates NFκ-B through binding TRAF6 at residues 1099–
1104 (UL37-TRAF6 dom) (Liu et al., 2008). Throughout UL37 are 17 dileucine motifs (LL or LI) and 3 tyrosine-based motifs (YXXΦ, whereΦ represents a large hydrophobic residue)
which may facilitate interactions with clathrin adaptor proteins to promote vesicular trafﬁcking (Boll et al., 1996; Kirchhausen et al., 1997; Kirchhausen, 1999; Wan et al., 1998).
Conserved residues span the length of UL37, with the exception of approximately 100 unconserved amino acids at the amino- and carboxy-termini.
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domains or UL37 self-association. The possibility that cellular proteins
bind UL36 and/or UL37 to facilitate the above interactions cannot be
dismissed entirely. Based upon the fact that the minimal binding
domains of UL36 and UL37 interact in cotransfected cells, it seems
unlikely that cellular factors are necessary for the interaction of UL36
and UL37. In addition, relatively small self-association domains of
UL37 coimmunoprecipitate in transfected cells, also suggesting that
cellular proteins are not necessary for interaction. Although we
suspect that cellular proteins are not necessary for the UL36-UL37
interaction or UL37 self-association, it is possible that cellular and/or
viral proteins may enhance or facilitate these interactions in a variety
of ways.
The UL37 domains involved in interaction with UL36, as well as its
self-association, are located in the carboxy-terminal region of UL37.
We were curious if UL37 binds to molecules of UL36 and UL37 at the
same time, forming a complex. From cells cotransfected with UL37HA,
UL37GFP and UL36.512-767GFP, we observed that as the amount of
UL36.512-767GFP protein increased, the amount of UL37GFP that co-
immunoprecipitated with UL37HA decreased (Fig. 8). Thus, it appears
that UL36.512-767GFP competes with UL37GFP for binding to
UL37HA. It may be possible that binding of UL36 to UL37 alters the
conformation of UL37, resulting in steric hindrance that prevents the
self-association of UL37. The role that self-association of UL37 may
play during infection is unclear. When UL37HA and UL37GFP are
cotransfected into cells that are subsequently infectedwith HSV-1, the
self-association of UL37HA and UL37GFP is readily detected in coim-
munoprecipitation assays (data not shown). Although UL37 is over-
expressed through transient transfection in this experimental design,
it appears that UL37 does self-associate within the infected cell. Fuchs
and colleagues reported that deletion of the domain of UL36 necessary
for binding UL37 does not abrogate PRV virus production, but reduces
viral titers by 50-fold and produces capsids within the cytoplasm in
large ordered structures (Fuchs et al., 2004). Therefore, it appears that
in PRV, UL36 is not required to interact with UL37 in order to execute
its essential function. UL37 plays a critical role for assembly of HSV-1,
but is not strictly essential for PRV replication. The function and/or
necessity of the UL36-UL37 interaction may differ among HSV-1 and
PRV. It is not yet understood if UL37 is dependent on the UL36-UL37
interaction to perform its essential function during HSV-1 infection.
Similarly, it is unknown if the self-interaction of UL37 plays a vital role
in virus replication. Exactly how the competition between UL36 and
UL37 to bind UL37 may impact virus assembly is unclear.
The amount of HSV-1 UL37 packaged into virions is tightly con-
trolled (McLauchlan, 1997). Furthermore, relatively few copies of
HSV-1 UL36 are packaged into virions, an estimated 100–150 copies
per virion (Heine et al., 1974). Based upon the incorporation of UL36
and UL37, it is possible that the protein levels of UL37 and UL36within
the infected cell may also be tightly controlled. Protein levels of theUL36 homologue of human cytomegalovirus have been reported to be
dependent on the presence of the UL37 homologue (Bechtel and
Shenk, 2002). Therefore, protein levels of UL36 and UL37 within the
infected cell may also regulate the competition between UL36 and
UL37 for binding with other molecules of UL37. One may speculate
that the self-association of UL37 and the interaction of UL37 with
UL36 may play roles at different sites of the infected cell. Although
UL37 and UL36 are binding partners, it is likely that they are not
always in abundance at the exact same locations within the cell, thus
allowing UL37 to self-associate in some locations and bind UL36 in
others.
In an effort to identify regions of UL37 that perform necessary
functions for assembly of infectious particles, plasmids encoding regions
of UL37were transfected into cells thatwere subsequently infectedwith
the UL37 deletion virus, KΔUL37. Cells and media were harvested and
analyzed by plaque assays to identify the regions of UL37 that rescue the
replication defective virus. Surprisingly, the only region of UL37 that
provided partial complementationwas the region encoding amino acids
568–1123. The domain involved in UL36 binding and a self-association
domain are located within this region. However, other truncation
mutants that are capable ofUL36binding, such asUL37.301-1123HAand
UL37.1-809HA,were not able to rescue themutant virus. Similarly, other
UL37 truncation mutants capable of self-association were not able to
complement KΔUL37. It is difﬁcult to interpret what these results teach
us about the essential function of UL37. It is possible that UL37 mutant
proteinsmay perform a dominant-negative functionwithin the infected
cell, interacting with binding partners, but in a manner that disrupts
virus assembly. Similarly, it is also unclear if the failure of UL37 mutant
proteins to rescueKΔUL37maybe attributed to aberrant conformational
structures that inhibit UL37 from performing essential function(s)
during infection. Several truncation mutants that are capable of binding
UL36 and/or self-association in transfection–immunoprecipitation as-
says also did not rescue the UL37 deletion virus. These results may also
suggest thatUL37performs a function, in addition to self-association and
UL36 binding, that maps to residues 568–1123 and is necessary for
productive infection. The speciﬁc essential function(s) that UL37 plays
during virus assembly remains to be determined.
UL37.568-1123HA was the only truncation mutant analyzed that
was able to partially complement KΔUL37. To determine if this com-
plementationmight possibly be attributable to the ability of UL37.568-
1123HA to interact with UL36, it was necessary to demonstrate the
interaction of UL37.568-1123HA with full-length virus-expressed
UL36. Coimmunoprecipitation from transfected-infected cytoplasmic
lysates lacking capsid structures veriﬁed that UL37.568-1123HA is
capable of interacting with virus-expressed full-length UL36 in K23Z-
infected cells (Fig. 10), in addition to binding UL36.512-767GFP in
transfected cells (Fig. 1). Based on these results, it seems likely that
UL37.568-1123HA also interacts with virus-expressed UL36 in
KΔUL37-infected cells. The interaction of UL37.568-1123HA and
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complementation of KΔUL37 seen in Fig. 9.
It is also intriguing if self-associationofUL37plays anessential role in
infection. It is clear that UL37 and UL37 truncation mutants self-
associate in transfected cells (Figs. 5–7), but the occurrence of the
interaction is more difﬁcult to interpret in infected cells. UL37HA and
UL37GFP readily coimmunoprecipitate from cotransfected cells subse-
quently infectedwith HSV-1 K23Z, KΔUL37 or KΔUL36, a virus that fails
to expressmost of the UL36 open reading frame (Desai, 2000) (data not
shown). However, in this experimental scenario, expression of plasmid-
encodedUL37 is presumably altered in kinetics and increased in amount
as compared to virus-expressed UL37. Attempts were also made to
coimmunoprecipitate UL37.568-1123HA from K23Z-infected cells. In
these analyses UL37.568-1123HA showed minimal levels of binding to
virus-expressed UL37 (data not shown). However, virus-expressed
UL37 and UL37HA differ in only 9 amino acids in size andmigrate at the
same location on an SDS-PAGE gel. Therefore, the low level of binding of
UL37.568-1123HA cannot be directly compared with a level of
coimmunoprecipitation of transiently expressed full-length UL37HA
in the virus-infected cells and thus lacks clear interpretation. In spite of
several attempts, it remains to bedetermined if self-association of virus-
expressed UL37 occurs within the virus-infected cell and/or plays an
essential role in virus infection.
Materials and methods
Cells and viruses
Vero cells (ATCC CCL-81) were grown in Dulbecco's modiﬁed
Eagles medium (DMEM) supplemented with 5% fetal bovine serum
(FBS), 2.25% sodium bicarbonate, 25 mM HEPES buffer, glutamine
(300 μg/ml), penicillin (100 μg/ml) and streptomycin (131 μg/ml).
Infected cells were grown in DMEMwith a reduced FBS concentration
of 2%. HSV-1 KOS strain was used as the wild type strain (Smith,
1964). A UL37 deletion virus, KΔUL37, and Vero cell line that stably
expresses UL37 (BD45) were kind gifts from Desai et al.(2001). BD45
cells were grown in DMEM with 5% FBS. K23Z HSV-1 was also a kind
gift from Desai et al.(1993).
Antibodies
Rabbit anti-HA antisera used for Western blotting and immunopre-
cipitation were purchased from Sigma. Goat anti-HA antibody used for
Western blotting was purchased from Santa Cruz. Rabbit polyclonal
anti-GFP antibody used for Western blotting was kindly provided by
John Wills, Penn State College of Medicine. Goat polyclonal anti-GFP
antibody used for Western blotting and immunoprecipitation was
purchased from Rockland. Rabbit TrueBlot HRP-conjugated anti-rabbit
antibody was purchased from eBioscience. Rabbit polyclonal anti-UL36
antibody was described previously (McNabb and Courtney, 1992).
Cloning
The UL37 gene was ampliﬁed from the HSV-1 KOS genome by PCR
ampliﬁcation using Platinum Pfx polymerase (Invitrogen). A forward
primer containing a BglII site 50 bpupstreamof the start codon of UL37
and a reverse primer containing an EcoRI site in place of the stop codon
of UL37 were used for ampliﬁcation. The DNA product was digested
with EcoRI and BglII and ligated into the vector pEGFP-n2 (Clontech)
also digested with the same restriction enzymes. Two separate clones
produced from separate PCR reactionswere sequenced and compared.
Amino acid sequences of the UL37 codons were identical and one
plasmid was selected and designated UL37GFP.
The UL37HA plasmid was generated by excising the UL37 frag-
ment from the UL37GFP plasmid, described above, using EcoRI and
BglII. This fragment was ligated into a hemagglutinin (HA) containingplasmid, UL46HA (Murphy et al., 2008) that was digested with the
same restriction enzymes. The parental vector of the UL46HA plasmid
was the pEGFP-n2 GFP vector that was previously modiﬁed to replace
the GFP sequence with the HA sequence (Loomis et al., 2006). The
newly constructed plasmid, UL37HA, was sequenced to ensure that
UL37 was in frame with HA.
UL37 C-terminal GFP and HA truncationmutants were constructed
by using the forward primer used to make the UL37GFP plasmid and a
reverse primer that contains an EcoRI site immediately downstream of
the truncation site. The PCR products were digested with BglII and
EcoRI and ligated into UL37GFP or UL46HA plasmids digested with the
same restriction enzymes. The resulting inserts were sequenced to
ensure that they contained the speciﬁed UL37 truncation sequences
and were in frame with GFP or HA.
To construct the UL37HA N-terminal truncation mutants, the
UL37HA plasmid was modiﬁed to contain a HindIII restriction enzyme
site immediately upstream of the start codon of UL37. The QuickChange
II XL Site-Directed Mutagenesis kit (Stratagene) was used according to
themanufacturer's instructions to insert theHindIII site into theUL37HA
plasmid to generate the UL37HA-HindIII plasmid. UL37HA-HindIII
plasmid contains 50 bp of genomic sequence upstream of the UL37
start site, followed by a HindIII restriction site immediately upstream of
the ﬁrst UL37 amino acid. UL37HAN-terminal truncationmutantswere
ampliﬁedwith forward primers containing aHindIII site and start codon
immediately upstream of the ﬁrst codon of the speciﬁed truncation
mutant. The reverse primer used was the same reverse primer utilized
to create the UL37HA plasmid and contains an EcoRI restriction site. The
above mentioned primers were used to amplify the mutant UL37
inserts,whichwere thendigestedwithHindIII and EcoRI and ligated into
UL37HA-HindIII plasmid previously digested with the same enzymes.
The resulting N-terminal UL37HA truncation mutants contained 50 bp
of genomic upstream sequence, a start codon, the truncated amino acid
sequence and theHA tag. TheUL37HA truncationmutant plasmidswere
sequenced to verify the correct mutant UL37 coding regions. The
UL37GFP N-terminal truncation mutants were constructed by excising
theUL37mutant fragments from the respective UL37HAplasmids using
EcoRI and BglII and then ligating the sequences into UL37GFP plasmid
previously digested with the same enzymes.
Plasmids containing internal sequences of UL37 were made by
amplifying the UL37 sequence with forward primers containing a
HindIII site and start codon immediately before the ﬁrst UL37 codon of
the mutant protein. Reverse primers contained an EcoRI site that was
immediately downstream of the last UL37 codon of the mutant pro-
tein. The insertswere ampliﬁed by PCR, digestedwithHindIII and EcoRI
and ligated into UL37.568-1123HA plasmid previously digested with
the same enzymes. The resulting plasmids contain 50 bp of HSV-1
sequence upstream of the UL37 start codon, followed by a methionine
start codon, the internal UL37 sequence and the HA tag.
UL37Δ568-809.HA and UL37Δ568-809.GFP were generated using
the QuickChange II XL Site-Directed Mutagenesis kit (Stratagene)
according to the manufacturer's instructions. PCR primers comple-
mentary to nucleotides encoding amino acids 563–567 and 810–814
were used to generate a PCR product from UL37HA and UL37GFP
templates, looping out codons 568–809 of UL37. Cloneswere screened
by restriction enzymedigestion and sequenced to verify the removal of
codons 568–809.
The UL36.512-767 gene fragment was ampliﬁed from HSV-1 KOS
genomic DNA by PCR ampliﬁcation using Platinum Pfx polymerase
(Invitrogen). A forward primer containing a BglII site and an ATG start
sequence immediately before codon 512 and a reverse primer con-
taining aMfeI site directly after codon 767 was used to amplify codons
512–767 of UL36. The ampliﬁed DNAwas digested with BglII andMfeI
and ligated into the vector pEGFP-n2 (Clontech) digested with BglII
and EcoRI. The resulting plasmid, UL36.512-767GFP, was sequenced to
verify the correct amino acid sequence and that the gene fragment
was in frame with the downstream GFP.
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Vero cells grown to approximately 90–95% conﬂuency in 60 mmor
100 mm plates were transfected with Lipofectamine 2000 (Invitro-
gen) according to the manufacturer's instructions. Approximately 20–
24 h post-transfection cells were washed twice with phosphate-
buffered saline (PBS) and harvested by scraping. Cells were pelleted
by centrifugation at 1000×g for 10 min at 4 °C and resuspended in 1%
NP40 lysis buffer (50 mM Tris–HCl pH 7.4, 150 mM NaCl, 2 mMMgCl,
1% NP40, 0.1% Sigma protease inhibitor cocktail). Cells were then
incubated on ice for 30 min and nuclei were pelleted by centrifugation
at 1000×g for 10 min at 4 °C. The cytoplasmic fraction was clariﬁed
further by centrifugation at 14,000 rpm for 5 min at 4 °C in a micro-
fuge. The cytoplasmic lysate was precleared for approximately 1 h
with protein G-agarose beads (Roche) that were washed three times
in lysis buffer. Protein G-agarose beads were pelleted at 14,000 rpm
for 5 min at 4 °C in a microfuge. Immunoprecipitation antibody was
added to the precleared samples and rocked at 4 °C for a minimum of
1 h. Protein G-agarose beads were added to the samples and rocked
overnight at 4 °C. Immune complexes were washed three times in
lysis buffer. 2× sample buffer (3.6% SDS, 18% βME, 114 mM Tris pH
6.8, 0.05% bromophenol blue and 18% glycerol) was added to the
beads and the immunoprecipitated material was separated by SDS-
PAGE, transferred to nitrocellulose membranes and analyzed by
Western blotting using the antibodies mentioned above, ECL reagents,
and autoradiography using Kodak BioMax XAR ﬁlm. For sequential
probing of the same nitrocellulose membrane, blots were submerged
in stripping buffer (60 mMTris–HCl, pH 8.0, 2% SDS and 0.75% βME) at
56 °C for approximately 35 min to remove bound antibodies. Al-
though results and interpretations are consistent between repetitions
of experiments, quantiﬁcation of immunoprecipitated material was
attempted but unsuccessful. Comparison of relative levels of binding
requires densitometric quantiﬁcation of four separate Western blots
for each repetition of an experiment. In some of these experiments the
density of the protein bands was not within linear range for all four
separate Western blots of an experiment. Therefore quantiﬁcation
and normalization could not be accurately performed.
Transfection–infection assay
Vero cells grown in 100 mmplates were transfected with Lipofecta-
mine 2000 (Invitrogen) according to the manufacturer's instructions.
Approximately 24 h post-transfection, cells were infected with HSV-1
K23Z (Desai et al., 1993) with an MOI of 10. Approximately 24 h after
infection, cells were harvested by scraping, washed twice with
phosphate-buffered saline (PBS) and immunoprecipitation, SDS-PAGE
and Western blotting were performed as described above.
Trans-complementation assay
Vero cells grown in 60 mm plates to approximately 90–95% con-
ﬂuency were transfected with the indicated plasmids using Lipofecta-
mine 2000 (Invitrogen) according to the manufacturer's instructions.
Approximately 24 h after transfection cells were infected with KΔUL37
HSV-1 at an MOI of 1. Infected cells were grown in 3.5 ml of DMEM
containing 2% FBS. At 48 h after infection, media and cells were
collected. Cells were lysed by three cycles of freeze thaw and cell debris
was pelleted by centrifugation at 750×g for 10 min at 4 °C. Cellular
debris was analyzed by SDS-PAGE and Western blotting to verify
expression of the transfected plasmids. Media supernatant was stored
at −80 °C before analysis by plaque assay. The amount of infectious
virions in the media supernatant was determined by plaque titration
assays on BD45 cells. Titrations were performed in duplicate. Each
plasmid was analyzed for trans-complementation a minimum of three
times and results of the independent titrations were averaged and
presented as percent PFU/ml as compared to full-length UL37HA.Acknowledgments
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